Company Information

Company UCB SA/NV
www.ucb.com
Type:
Company
Country:
Belgium
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
13 January 2021
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Affiliated Subsidiaries

Country Company Name
France UCB Pharma S.A.
United States of America UCB, Inc.
Switzerland UCB Farchim SA
Italy UCB Pharma SpA
Spain UCB PHARMA, S.A.

Communication On Progress

Published On Title Level/Status
01-Aug-2024 2024 Communication on Progress Submitted
03-Mar-2022 UCB Integrated Annual report Active
29-Nov-2021 Grace Letter Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.